NCT00293072
- Conditions
- ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +11 more
- Locations
-
- Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom
Clinical trial condition
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.
112 public trials
49 recruiting studies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results
Active, Not Recruiting
Avacostar - (PASS)
NCT05897684
- Conditions
- ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
- Locations
-
- Charité University Medicine Berlin, Germany
- University Hospital of Cologne Cologne, Germany
- Municipal Hospital Dresden Dresden, Germany
- University Hospital Essen Essen, Germany
Active, Not Recruiting
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941
- Conditions
- Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +18 more
- Locations
-
- Arizona Arthritis and Rheumatology Research PLLC Mesa, Arizona, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
- Novartis Investigative Site CABA, Buenos Aires, Argentina
- Novartis Investigative Site La Plata, Buenos Aires, Argentina
Active, Not Recruiting
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
NCT04664465
- Conditions
- ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +34 more
- Locations
-
- CHU d'Angers Angers, France
- CHRU de Brest Brest, France
- CHD Vendée La Roche-sur-Yon, France
- CH Le Mans Le Mans, France
Active, Not Recruiting
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
NCT03323476
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +22 more
- Locations
-
- Centre Hospitalier Universitaire Amiens Amiens, France
- CHU Angers Angers, France
- Centre Hospitalier Angoulême Angoulême, France
- Centre Hospitalier ARRAS Arras, France
Active, Not Recruiting
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
NCT06152172
- Conditions
- ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +29 more
- Locations
-
- Hospital of the Universithy of Pennsylvania Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
NCT06294236
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +33 more
- Locations
-
- University of Colorado Aurora, Colorado, United States
- Emory University Atlanta, Georgia, United States
- Johns Hopkins Hospital Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
NCT05732402
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
- Locations
-
- Investigational Site (523) Phoenix, Arizona, United States
- Investigational Site (501) Phoenix, Arizona, United States
- Investigational Site (524) Tucson, Arizona, United States
- Investigational Site (506) Valencia, California, United States
Active, Not Recruiting
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
NCT05630612
- Conditions
- ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +14 more
- Locations
-
- Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent Edinburgh, United Kingdom
Active, Not Recruiting
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
NCT06656962
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN), Autoimmune Diseases, +8 more
- Locations
-
- Renmin hospital of Wuhan University Wuhan, Hubei, China